Furthermore, in conjunction with Takeda G protein-coupled receptor 5, FXR has been shown to induce human PPARα and PPARγ coactivator protein-1α, the activities of which promote increases in mitochondrial oxidative phosphorylation and energy metabolism, thereby reducing the likelihood of obesity and diabetes (58). Here, PPARA is linked to obesity disorder.